Geode Capital Management LLC increased its position in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 6.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,834,659 shares of the company's stock after purchasing an additional 110,149 shares during the period. Geode Capital Management LLC owned 1.13% of Integral Ad Science worth $19,836,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Healthcare of Ontario Pension Plan Trust Fund bought a new stake in Integral Ad Science in the second quarter worth about $4,724,000. abrdn plc lifted its position in shares of Integral Ad Science by 12.5% during the 3rd quarter. abrdn plc now owns 2,147,656 shares of the company's stock valued at $23,216,000 after acquiring an additional 237,930 shares during the last quarter. Invenomic Capital Management LP boosted its stake in shares of Integral Ad Science by 57.4% during the 3rd quarter. Invenomic Capital Management LP now owns 585,309 shares of the company's stock worth $6,327,000 after acquiring an additional 213,488 shares in the last quarter. Rice Hall James & Associates LLC acquired a new position in shares of Integral Ad Science in the 3rd quarter worth $1,795,000. Finally, Washington Harbour Partners LP purchased a new stake in shares of Integral Ad Science during the third quarter valued at $1,744,000. 95.78% of the stock is owned by institutional investors.
Integral Ad Science Stock Performance
Integral Ad Science stock traded down $0.03 during mid-day trading on Friday, reaching $10.44. The company had a trading volume of 547,182 shares, compared to its average volume of 1,327,074. Integral Ad Science Holding Corp. has a 52 week low of $7.98 and a 52 week high of $17.53. The company has a quick ratio of 3.71, a current ratio of 3.71 and a debt-to-equity ratio of 0.07. The firm has a market cap of $1.70 billion, a price-to-earnings ratio of 52.20, a PEG ratio of 1.49 and a beta of 1.45. The company has a 50 day moving average of $11.11 and a 200-day moving average of $10.75.
Integral Ad Science (NASDAQ:IAS - Get Free Report) last announced its quarterly earnings results on Tuesday, November 12th. The company reported $0.10 EPS for the quarter, topping analysts' consensus estimates of $0.08 by $0.02. The firm had revenue of $133.50 million during the quarter, compared to analysts' expectations of $138.06 million. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The company's revenue for the quarter was up 11.0% compared to the same quarter last year. During the same quarter last year, the company earned ($0.09) earnings per share. On average, sell-side analysts expect that Integral Ad Science Holding Corp. will post 0.26 EPS for the current fiscal year.
Insiders Place Their Bets
In other news, CEO Lisa Utzschneider sold 10,481 shares of the stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $10.11, for a total transaction of $105,962.91. Following the sale, the chief executive officer now directly owns 239,709 shares of the company's stock, valued at $2,423,457.99. This represents a 4.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Tania Secor sold 5,240 shares of the business's stock in a transaction that occurred on Monday, October 7th. The stock was sold at an average price of $10.11, for a total transaction of $52,976.40. Following the completion of the transaction, the chief financial officer now owns 248,223 shares of the company's stock, valued at $2,509,534.53. This trade represents a 2.07 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 16,363 shares of company stock valued at $165,629. 2.00% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
IAS has been the topic of several recent analyst reports. Truist Financial cut their price objective on Integral Ad Science from $18.00 to $16.00 and set a "buy" rating on the stock in a report on Wednesday, November 13th. Oppenheimer decreased their price objective on shares of Integral Ad Science from $20.00 to $18.00 and set an "outperform" rating for the company in a research note on Wednesday, November 13th. Craig Hallum reduced their target price on Integral Ad Science from $18.00 to $16.00 and set a "buy" rating for the company in a report on Wednesday, November 13th. Benchmark reissued a "hold" rating on shares of Integral Ad Science in a research report on Thursday, November 14th. Finally, Piper Sandler decreased their price objective on Integral Ad Science from $18.00 to $16.00 and set an "overweight" rating for the company in a research report on Wednesday, November 13th. Four analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $15.18.
Read Our Latest Stock Analysis on Integral Ad Science
Integral Ad Science Company Profile
(
Free Report)
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Recommended Stories
Before you consider Integral Ad Science, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integral Ad Science wasn't on the list.
While Integral Ad Science currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report